Validation of the GenesWell BCT Score in Young Asian Women With HR+/HER2− Early Breast Cancer
出版年份 2021 全文链接
标题
Validation of the GenesWell BCT Score in Young Asian Women With HR+/HER2− Early Breast Cancer
作者
关键词
-
出版物
Frontiers in Oncology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-02-23
DOI
10.3389/fonc.2021.588728
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Summary of head-to-head comparisons of patient risk classifications by the 21-gene Recurrence Score® (RS) assay and other genomic assays for early breast cancer
- (2019) Zsuzsanna Varga et al. INTERNATIONAL JOURNAL OF CANCER
- Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians versus the US Population
- (2019) Ching-Hung Lin et al. JNCI-Journal of the National Cancer Institute
- Insights Into Breast Cancer in the East vs the West
- (2019) Yoon-Sim Yap et al. JAMA Oncology
- Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
- (2019) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer
- (2019) Mi Jeong Kwon et al. Frontiers in Oncology
- Emerging immune gene signatures as prognostic or predictive biomarkers in breast cancer
- (2019) Mi Jeong Kwon ARCHIVES OF PHARMACAL RESEARCH
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
- (2018) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures
- (2018) Zhengyan Kan et al. Nature Communications
- BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer
- (2018) Mi Jeong Kwon et al. PLoS One
- Basic Facts of Breast Cancer in Korea in 2014: The 10-Year Overall Survival Progress
- (2017) Eun Hwa Park et al. Journal of Breast Cancer
- A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2− early breast cancer
- (2017) Gyungyub Gong et al. Scientific Reports
- Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival
- (2016) Ann H. Partridge et al. JOURNAL OF CLINICAL ONCOLOGY
- 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
- (2016) Fatima Cardoso et al. NEW ENGLAND JOURNAL OF MEDICINE
- The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial
- (2015) F Fitzal et al. BRITISH JOURNAL OF CANCER
- Prediction of Late Distant Recurrence After 5 Years of Endocrine Treatment: A Combined Analysis of Patients From the Austrian Breast and Colorectal Cancer Study Group 8 and Arimidex, Tamoxifen Alone or in Combination Randomized Trials Using the PAM50 Risk of Recurrence Score
- (2015) Ivana Sestak et al. JOURNAL OF CLINICAL ONCOLOGY
- Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
- (2013) M. Gnant et al. ANNALS OF ONCOLOGY
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Prospective Observational Study of Breast Cancer Treatment Outcomes for UK Women Aged 18–40 Years at Diagnosis: The POSH Study
- (2013) Ellen Copson et al. JNCI-Journal of the National Cancer Institute
- A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors
- (2011) Martin Filipits et al. CLINICAL CANCER RESEARCH
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. Journal of Oncology Practice
- Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer
- (2009) Wonshik Han et al. BREAST CANCER RESEARCH AND TREATMENT
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now